Rouven Bergmann insider trades: Medidata Solutions (MDSO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rouven reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 6, 2019 | MDSO | ↓ Sell10b5-1 | 12,512 | $75.00 | $938K | Direct | Feb 7, 2019 (1d) |
| Dec 3, 2018 | MDSO | ↓ Sell10b5-1 | 10,000 | $79.00 | $790K | Direct | Dec 4, 2018 (1d) |
| Nov 28, 2018 | MDSO | ↓ Sell10b5-1 | 10,000 | $75.00 | $750K | Direct | Nov 30, 2018 (2d) |
| Sep 4, 2018 | MDSO | ↓ Sell10b5-1 | 20,000 | $84.24 | $1.7M | Direct | Sep 6, 2018 (2d) |
| Jul 19, 2018 | MDSO | ↓ Sell10b5-1 | 3,000 | $85.36 | $256K | Direct | Jul 20, 2018 (1d) |
| Jun 19, 2018 | MDSO | ↓ Sell10b5-1 | 3,000 | $82.85 | $249K | Direct | Jun 21, 2018 (2d) |
| May 21, 2018 | MDSO | ↓ Sell | 3,000 | $75.52 | $227K | Direct | May 23, 2018 (2d) |
| Apr 19, 2018 | MDSO | ↓ Sell10b5-1 | 4,000 | $71.50 | $286K | Direct | Apr 20, 2018 (1d) |
| Mar 19, 2018 | MDSO | ↓ Sell10b5-1 | 2,000 | $66.30 | $133K | Direct | Mar 21, 2018 (2d) |
| Mar 9, 2018 | MDSO | ↓ Sell10b5-1 | 1,000 | $70.00 | $70K | Direct | Mar 13, 2018 (4d) |
| Feb 20, 2018 | MDSO | ↓ Sell10b5-1 | 2,000 | $67.47 | $135K | Direct | Feb 22, 2018 (2d) |
| Jan 24, 2018 | MDSO | ↓ Sell10b5-1 | 3,000 | $70.00 | $210K | Direct | Jan 26, 2018 (2d) |
| Jan 19, 2018 | MDSO | ↓ Sell10b5-1 | 2,000 | $66.46 | $133K | Direct | Jan 22, 2018 (3d) |
| Dec 19, 2017 | MDSO | ↓ Sell10b5-1 | 2,000 | $65.95 | $132K | Direct | Dec 20, 2017 (1d) |
| Nov 30, 2017 | MDSO | ↓ Sell10b5-1 | 2,000 | $65.40 | $131K | Direct | Dec 4, 2017 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Rouven Bergmann's insider trades
Rouven Bergmann is Chief Financial Officer at Medidata Solutions (MDSO). Since Nov 30, 2017, Rouven has reported no open-market purchases and 15 sales worth $6.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
14 sales (96% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (10 filings), grants and awards (5 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDSO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.